1. Screening and identification of potent α-glycosidase inhibitors from Gardenia jasminoides Ellis.
- Author
-
Hua, D., Luo, W., Duan, J., Jin, D., Zhou, X., Sun, C., Wang, Q., Shi, C., Jiang, Z., Wang, R., Rao, C., Yu, S., Li, S., and Tang, S.
- Subjects
- *
GLYCOSIDASE inhibitors , *TRIADENUM virginicum , *GLUCOAMYLASE , *SIGNAL recognition particle receptor , *PLANT inoculation - Abstract
Abstract The α-glycosidase inhibition assay is used to examine the inhibition activity of traditional Chinese medicines through extraction with methanol. The α-glycosidase inhibition activity of the isolated compounds is measured by α-glycosidase inhibition assay and compared with Acarbose. Molecular docking is implemented to study the interaction between isolated compounds and CtMGAM (maltase–glucoamylase-C) or NtMGAM (maltase–glucoamylase-N). Compared with those of Acarbose, the methanol extract of Gardenia jasminoides Ellis has a higher activity to inhibit α-glycosidase among the 74 traditional Chinese medicines. Geniposide and Gardenoside, isolated compounds from Gardenia jasminoides Ellis , have better inhibition activity (IC 50 values of 0.35 and 0.46 mg/ml, respectively) than Acarbose (IC 50 values of 0.75 mg/ml). The molecular docking results show that Geniposide and Gardenoside have specific binding affinities with CtMGAM and can be considered comparable to those of Acarbose. Our findings illuminate the possible anti-diabetic mechanism of Gardenia jasminoides Ellis and support its use for the treatment of diabetes. Highlights • We illuminate the anti-diabetic mechanism for supporting the use of Geniposide and Gardenoside in the near future. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF